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Abstract:  Inflammation  and  cardiovascular  disease  are  associated  with  elevated  serum  levels  of  C-Reactive  Protein  (CRP)  and 
  homocysteine. The presence of both molecules in saliva provides an opportunity for development of non-invasive assessments of 
disease risk. However, salivary CRP and homocysteine reference ranges and their correlation with serum levels are unknown. This 
study investigated if CRP and homocysteine could be routinely detected in the saliva of healthy adults and the relationship between 
salivary and blood levels. CRP and homocysteine concentrations were determined using ELISA and enzymatic assays respectively. 
Homocysteine was detected in only two saliva samples (n = 55). CRP was measurable in all saliva samples (range: 0.05 to 64.3 µg/L; 
median = 1.2 µg/L) and plasma samples (range: 0.14 to 31.1 mg/L; median = 2.0 mg/L). Regression analysis demonstrated no relation-
ship between CRP concentration in saliva and plasma (R2 = 0.001). Generalized linear models including variables such as saliva flow 
rate and time since eating or drinking also did not pass lack of fit testing. Therefore, a relationship between CRP concentration in saliva 
and blood could not be established in this group of subjects. More sensitive detection methods are needed to determine if a correlation 
between salivary and serum homocysteine levels exists.
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Introduction
The serum biomarkers homocysteine and C-reactive 
protein (CRP) are often used to assess cardiovascu-
lar disease risk.1 Homocysteine is a product of the 
methionine metabolic pathway that can accumulate 
as a result of folate, vitamin B12 or vitamin B6 defi-
ciency, kidney disease, or polymorphisms in enzymes 
regulating  its  metabolism.  Synthesis  of  the  acute 
phase protein CRP increases dramatically in response 
to infection, but mildly elevated levels are also asso-
ciated with chronic inflammation. The development 
of high sensitivity CRP assays has enabled reliable 
detection at these levels and several studies have dem-
onstrated that both CRP and homocysteine are useful 
biomarkers for predicting cardiovascular events and 
mortality in certain populations.2–5
Elevated serum levels of CRP and homocysteine 
have also been linked to obesity and related disorders 
including polycystic ovary syndrome, type II diabetes, 
and metabolic syndrome.6–8 These findings have gen-
erated interest in the potential use of these biomarkers 
to identify patients at the greatest risk of developing 
not just cardiovascular disease, but also other com-
plications of obesity. Such screening efforts would be 
simplified by the development of non-  invasive meth-
ods for measuring these molecules. Both CRP and 
homocysteine  have  been  detected  in  human  saliva 
suggesting  that  novel  approaches  to  assessing  dis-
ease risk and monitoring the response to treatment 
may be possible.9,10 However, reference ranges for 
salivary concentrations of these molecules have not 
been established. In addition, although a correlation 
between serum and salivary CRP concentration has 
been observed in pigs,11 this relationship has not been 
investigated in human subjects. The goal of the study 
reported here was to determine if homocysteine and 
CRP can be routinely detected in the saliva of healthy 
adults  and  to  investigate  the  relationship  between 
  salivary and blood levels of these molecules.
Methods
Subjects and sample collection
Study participants (n = 69) were recruited from the 
second-year  class  at  the  West  Virginia  School  of 
Osteopathic Medicine. The study was approved by 
the WVSOM Institutional Review Board and written 
informed consent was obtained from each participant. 
All subjects well enough to attend class on the day 
of the study were eligible to participate. The subjects 
were asked to fast for at least one hour prior to giving 
their blood and saliva samples. Data regarding time 
since eating and drinking were obtained and failure 
to meet the fasting requirements resulted in exclu-
sion from the study. Unstimulated whole saliva was 
obtained using the passive drool method and flow 
rates  were  determined.12  The  saliva  samples  were 
immediately placed on ice following collection and 
stored at -20 °C. Blood samples were collected by 
venipuncture  into  EDTA  tubes  and  were  immedi-
ately centrifuged to separate blood components. The 
plasma supernatants were transferred to cryotubes for 
storage and frozen at -20 °C.
homocysteine and C-reactive protein 
measurement
Prior to performing homocysteine and CRP assays, 
saliva and plasma aliquots were thawed at 4 °C and 
saliva samples were centrifuged for 15 minutes at 
1500 × g at 4 °C in order to pellet the mucins. Saliva 
supernatants were transferred to fresh tubes and total 
homocysteine  assays  were  performed  immediately. 
The  concentration  of  homocysteine  in  saliva  and 
plasma  was  determined  using  the Axis-Shield  liq-
uid stable two-reagent enzymatic assay kit (Dundee, 
Scotland).  Because  some  subjects  did  not  produce 
large  amounts  of  saliva,  the  protocol  was  slightly 
modified for measurement in small volumes using 
a 96-well format and full standard curve. The modi-
fied salivary homocysteine assay had intra- and inter- 
assay variability (%CV) of less than 10% and less 
than 15% respectively. Average recovery from saliva 
was 103% and the lower limit of detection (LLOD) 
for homocysteine in saliva was 0.8 µmol/L. Agree-
ment with the original protocol was verified using 
reference  materials  provided  by  Axis-Shield.  The 
LLOD for homocysteine in plasma using the standard 
kit protocol is 0.4 µmol/L with intra and inter-assay 
variability both less than 10%. The concentration of 
CRP in saliva was determined using a salivary CRP 
ELISA kit from Salimetrics, Inc (State College, PA). 
Intra- and inter-assay variability for this assay were 
less than 10% and recovery was 98%. CRP levels in 
plasma were determined using an AssayMax ELISA 
kit from Asssaypro (St. Charles, MO) Intra- and inter-
assay variability for this assay were also less than 
10% and recovery was 93%.Detection of salivary Crp and homocysteine in healthy adults
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Statistical analysis
All statistical analyses were completed using SPSS 
version 16 software. Subjects with missing data points 
were excluded. Because levels of CRP in serum and 
saliva lacked normal distribution, values were loga-
rithmically  transformed.  Shapiro-Wilk  testing  con-
firmed that the transformed data did not deviate from 
normality. Generalized linear modeling was used to 
determine the relationship between saliva and blood 
levels  of  the  biomarkers.  Variables  including  time 
since eating or drinking and salivary flow rate were 
also incorporated into the models. Pearson product-
moment correlation coefficients were  calculated to 
investigate the relationship between these parameters 
and biomarker concentrations.
Results and Discussion
Sixty-nine  subjects  were  recruited  from  a  class  of 
second-year medical students at WVSOM to partici-
pate in this study. Because students are a protected 
population, potentially identifying information was 
not linked to samples. The average age of the popula-
tion from which subjects were recruited was 26 with 
a range of 24–48 and 48% were female. Following 
exclusion of subjects for failure to meeting fasting 
requirements  or  problems  with  sample  collection, 
biomarker assays were performed with samples from 
55 subjects.
CRP  was  detected  in  all  saliva  samples  and 
ranged from 0.05 to 64.3 µg/L with a median value 
of  1.2  µg/L  (Table  1).  Plasma  CRP  concentration 
ranged from 0.14 to 31.1 mg/L (median = 2.0 mg/L) 
(Table 1). Box and whisker plots were constructed 
and two extreme outliers for salivary CRP (.3 times 
the interquartile range) were identified. One of these 
was also an extreme outlier for plasma CRP. Homo-
cysteine could only be detected in the saliva of two 
subjects (LLOD = 0.8 µmol/L). One of these subjects 
was an extreme outlier for salivary CRP but both had 
plasma homocysteine levels within the normal range 
(4–14 µmol/L).13
Because data for salivary and plasma CRP levels 
were not normally distributed, the values were loga-
rithmically transformed prior to regression analysis. 
Shapiro-Wilk testing confirmed that the transformed 
data did not deviate from normality. Linear regression 
analysis showed no correlation between salivary and 
plasma levels of CRP (Fig. 1). Removal of extreme 
outliers from the analysis did not result in a better 
fit. No significant relationship was seen even when 
values were corrected for salivary flow rate. General-
ized linear models including flow rate and time since 
eating and drinking in the analysis did not pass lack 
of fit testing and no correlation between flow rate 
(r = 0.078), time since eating (r = 0.039) or drinking 
(r = 0.055) and salivary CRP was found. These results 
are not consistent with findings from a study in pigs 
which demonstrated a significant linear relationship 
between salivary and serum CRP levels.11 However, 
the majority of the animals used in this analysis had 
experimentally  induced  inflammation  and  serum 
CRP levels that were more than 5-fold greater than 
baseline.
Five of the subjects in our study had blood CRP 
concentrations higher than 10 mg/L, levels typically 
associated  with  infection,  myocardial  infarction  or 
non-infectious  inflammatory  pathologies  such  as 
arthritis.1 In these five subjects, a trend suggesting 
Table 1. Crp levels in saliva and plasma of healthy adult 
subjects  (n  =  55).  Standard  deviations  are  shown  with 
mean values.
salivary 
cRp (μg/L)
plasma 
cRp (mg/L)
range 0.05 – 64.3 0.14 – 31.1
Median 1.2 2
Mean  5.0 + 10.4 4.3 ± 5.9
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Figure 1. relationship between salivary and plasma Crp levels. Data 
for Crp concentration were not normally distributed. Therefore, values 
for both salivary and plasma concentration were logarithmically trans-
formed prior to analysis.Dillon et al
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a  linear  relationship  with  salivary  levels  could  be 
seen but was not statistically significant (R = 0.705, 
P = 0.12). These results suggest that while salivary 
CRP measurement may be a potential surrogate for 
blood measurement in conditions such as infection 
or  myocardial  infarction,  it  may  not  be  useful  for 
determining cardiovascular disease risk in otherwise 
healthy adults. One study using chip-based sensors 
concluded that measuring salivary CRP along with 
several other molecules could aid in the diagnosis of 
acute myocardial infarction.14 Therefore, additional 
studies investigating the diagnostic uses of salivary 
CRP would be of interest.
A limitation of this study is that information regard-
ing oral health status was not collected. Some studies 
have suggested that elevated salivary CRP levels are 
associated with periodontal disease.9,15 Therefore, sal-
ivary CRP concentration may be more indicative of 
oral health than of systemic inflammation. However, 
elevated serum CRP levels have also been reported 
in periodontal disease and little information on the 
source of salivary CRP is available.16 Although some 
molecules  diffuse  or  are  actively  transported  into 
saliva from the blood, others are synthesized by the 
salivary glands. CRP is primarily synthesized in the 
liver but one study has demonstrated increased CRP 
mRNA expression in the submandibular glands of rats 
with experimentally induced inflammation.17 If CRP 
is synthesized by salivary glands, a correlation with 
serum levels would not necessarily be expected.
Another limitation of this study is that the homo-
cysteine detection methods used were not sensitive 
enough to measure the low levels found in saliva. A 
previous study investigating salivary homocysteine 
using liquid chromatography reported a mean con-
centration of 1.34 µmol/L but only eight subjects were 
used.10 Our results confirm that homocysteine can be 
detected in saliva but the LLOD for the enzymatic 
assay used here was 0.8 µmol/L. This is close to the 
mean value reported previously and the development 
of more sensitive assay methods will be needed in 
order to investigate the use of salivary homocysteine 
as a diagnostic tool.10
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